Amino Technologies (AMO LN) FY’17 in line with cash well ahead of expectations | Consort Medical (CSRT LN) In line interims, still waiting for a catalyst | First Derivatives (FDP LN)
First investment by FD/BGF strategic partnership | FreeAgent (FREE LN) Emerging banking channel; Practice growth tempers | Gateley (GTLY LN) In line interim results, seasonally stronger H2 expected | iomart Group (IOM LN) Solid interims with bolt-ons establishing eCommerce presence | mporium Group (MPM LN) Seven fi ....

05 Dec 2017
N+1 Singer - Morning Song 05-12-2017
Consort Medical (CSRT:LON), 0 | ZIGUP PLC (ZIG:LON), 317 | Victrex plc (VCT:LON), 718 | Aferian plc (AFRN:LON), 2.4 | iomart Group plc (IOM:LON), 21.8 | WYG (WYG:LON), 0 | Mporium Group (MPM:LON), 0 | PCI-PAL PLC (PCIP:LON), 47.7 | Realm Therapeutics (RLM:LON), 0 | Gateley (Holdings) Plc (GTLY:LON), 127 | FreeAgent (FREE:LON), 0 | Oxford BioMedica plc (OXB:LON), 567

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Morning Song 05-12-2017
Consort Medical (CSRT:LON), 0 | ZIGUP PLC (ZIG:LON), 317 | Victrex plc (VCT:LON), 718 | Aferian plc (AFRN:LON), 2.4 | iomart Group plc (IOM:LON), 21.8 | WYG (WYG:LON), 0 | Mporium Group (MPM:LON), 0 | PCI-PAL PLC (PCIP:LON), 47.7 | Realm Therapeutics (RLM:LON), 0 | Gateley (Holdings) Plc (GTLY:LON), 127 | FreeAgent (FREE:LON), 0 | Oxford BioMedica plc (OXB:LON), 567
- Published:
05 Dec 2017 -
Author:
Singer CM Team -
Pages:
23 -
Amino Technologies (AMO LN) FY’17 in line with cash well ahead of expectations | Consort Medical (CSRT LN) In line interims, still waiting for a catalyst | First Derivatives (FDP LN)
First investment by FD/BGF strategic partnership | FreeAgent (FREE LN) Emerging banking channel; Practice growth tempers | Gateley (GTLY LN) In line interim results, seasonally stronger H2 expected | iomart Group (IOM LN) Solid interims with bolt-ons establishing eCommerce presence | mporium Group (MPM LN) Seven fi ....